van Bekkum D W
Introgene BV, The Netherlands.
J Clin Immunol. 2000 Jan;20(1):10-6. doi: 10.1023/a:1006682225181.
A review of the experiments with animal models of autoimmune disease (AID) that have provided the rationale for the present clinical investigations on the use of autologous stem cells for treating patients with severe refractory AID. The various types of AID in laboratory animals and the recognition of the key-role of hematopoietic stem cells (HSC) in AID are discussed. Two animal models were employed for translational research on autologous bone marrow transplantation (BMT): adjuvant arthritis (AA) as model for rheumatoid arthritis (RA) and experimental allergic encephalomyelitis (EAE) as model for multiple sclerosis (MS). The principal aspects of the treatment, i.e., conditioning agents and doses and T cell depletion of the autograft, were investigated in relation to remission induction and the incidence of relapses.
对自身免疫性疾病(AID)动物模型实验的综述,这些实验为目前使用自体干细胞治疗重度难治性AID患者的临床研究提供了理论依据。讨论了实验动物中各种类型的AID以及造血干细胞(HSC)在AID中的关键作用。采用了两种动物模型进行自体骨髓移植(BMT)的转化研究:佐剂性关节炎(AA)作为类风湿关节炎(RA)的模型,实验性变态反应性脑脊髓炎(EAE)作为多发性硬化症(MS)的模型。针对缓解诱导和复发率,研究了治疗的主要方面,即预处理药物及剂量和自体移植物的T细胞清除。